Bank of New York Mellon Financing Receivables Individually Evaluated for Impairment decreased by 51.4% to $157.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 36.4%, from $247.00M to $157.00M. Over 5 years (FY 2020 to FY 2025), Financing Receivables Individually Evaluated for Impairment shows an upward trend with a 51.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates rising credit stress among specific large borrowers, while a decrease suggests successful resolution or reduction of troubled assets.
This metric measures the carrying amount of specific financing receivables that have been identified as impaired and are...
Standard disclosure for banks to provide transparency into their non-performing or impaired loan portfolios.
financing_receivable_impairment_individual| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $44.00M | $60.00M | $130.00M | $140.00M | $136.00M | $90.00M | $79.00M | $68.00M | $113.00M | $117.00M | $303.00M | $348.00M | $301.00M | $286.00M | $247.00M | $279.00M | $199.00M | $323.00M | $157.00M |
| QoQ Change | — | +36.4% | +116.7% | +7.7% | -2.9% | -33.8% | -12.2% | -13.9% | +66.2% | +3.5% | +159.0% | +14.9% | -13.5% | -5.0% | -13.6% | +13.0% | -28.7% | +62.3% | -51.4% |
| YoY Change | — | — | — | — | +209.1% | +50.0% | -39.2% | -51.4% | -16.9% | +30.0% | +283.5% | +411.8% | +166.4% | +144.4% | -18.5% | -19.8% | -33.9% | +12.9% | -36.4% |